Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
Delia Bishara1, David Taylor1,21Pharmacy Department, South London and Maudsley NHS Foundation Trust, Denmark Hill, London, UK; 2Division of Pharmaceutical Sciences, King’s College, London, UKAbstract: Asenapine is a new atypical antipsychotic agent currently under development for the t...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2009
|
Subjects: | |
Online Access: | https://doaj.org/article/a505025bb6854ca5b5e8c41bb5f7597a |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!